State Street SPDR S&P Biotech ETF · $10.5B$12,576
XBIXBI vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,586
$10,000 five years ago, dividends reinvested · they hold 12.8% in common
XBIMeasureARKG
Returns · dividends reinvested
+27.2%Year to dateJan 1 → Nov 3+70.9%
+38.1%1 yearTotal return+59.0%
+34.5%3 years · per year$10,000 became $24,320 · $22,262+30.6%
+4.7%5 years · per year$10,000 became $12,576 · $6,586−8.0%
Cost and income
0.35%Expense ratio$35 · $75 a year on $10k · lower is better0.75%
0.35%Trailing 12-mo yield$35 · $0 a year on $10k0.00%
Risk · past year
−14.9%Worst dropSmaller is better−27.5%
29.1%VolatilityLower is calmer45.8%
XBIARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
6–2XBI wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns